Tiefenbacher Group renovation of our headquarters

Tiefenbacher Group renovation of headquarters in Hamburg

Tiefenbacher Group is keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.

This month we reopened our 3rd floor and we are happy to present you some of the results of the remodeling.

Our office is becoming a state-of-the-art and innovative workspace that reflects our culture of entrepreneurship, professionalism, and openness. The open-plan concept encourages creativity, collaboration, and teamwork among our employees. Overall, the interior is airy, transparent, and flooded with light.

The modernization also allowed us to integrate new decorative elements into the workspace. By this we also take the chance to represent the connection to our location in India. When installing the Tuk-tuk, some of our colleagues had to lend a hand and drag the vehicle up the stairs to the upper floor. This involved a lot of sweating and swearing. In the end, it was successfully put in its place and now stands there looking very inviting.

We are convinced that the new premises directly on the banks of the Elbe offer a great working environment that also promotes the growth and well-being of our employees. As hybrid working and working from home have become the new normal for many people, Tiefenbacher is keen to keep its workspace at the cutting edge.

Finally we would like to thank all the helpers once again. Naturally we are looking forward to showing you more pictures as soon as the final 4th floor is completed. The full modernization of our headquarters is expected to be completed later this year. We will keep you updated on the progress and look forward to welcoming you to our new offices soon!

Tiefenbacher Group renovation of our headquarters
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group invites young people to Girls’ & Boys’ Day

Tiefenbacher Group invites young people to Girls’ & Boys’ Day

Tiefenbacher Group invited some of our employees' children in Hamburg to spend a day with us at our headquarters to mark Germany's Future Day for young people.

The Girls’ & Boys’ Day or Future Day is a good opportunity not only to familiarize young people with the various career paths. It is also a perfect occasion to discuss gender stereotypes in the business world, role models, different life plans, and equality at the workplace.  Straightaway the boys and girls were divided between the various departments IT, Sales, Project Management, Business Development, and the canteen. Not only did they gain a better understanding of the departments’ areas of responsibility, but they were also able to realize their own ideas in small projects. Finally, the results of these projects have enabled our company to offer a different perspective on the needs of the younger generation in the field of pharmaceuticals.

However, we are delighted to have the opportunity to introduce a young generation of interested and open-minded people to our exciting world of pharmaceuticals. We hope to welcome many enthusiastic girls and boys to our company again next year.

Tiefenbacher Group invites young people to Girls’ & Boys’ Day
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group Earth Day 2024

Tiefenbacher Group celebrates Earth Day 2024

We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*.

Every year, Earth Day provides the keynote for a wide range of campaigns on the broad spectrum of environmental and climate protection for everyone to initiate and permanently implement their personal environmental agenda.

As a value-driven healthcare company, dedicated to improving the life of patients worldwide. We certainly recognise the importance of taking action to tackle the urgent climate crisis we face today. To achieve this goal, we are implementing a comprehensive sustainability strategy, which includes reducing our carbon footprint by cutting energy consumption through energy savings and efficiency measures.  This is correspondingly supported by the installation of large solar panels at our production sites and the use of exclusively electric company vehicles. With these measures, we already achieved a great interim goal of reducing our emissions by 80% by January this year.

Furthermore, we also have our direct impact on our environment in mind and therefore replanted trees and added further vegetation in the course of the conversion work on our properties in order to avoid further harming nature. In addition, we also filter microplastics using a reverse osmosis drinking water facility, so that not only is clean water provided for our schoolchildren in India, but we also minimise ecological disruption at the same time.

We believe that this is not only the right thing to do for the planet but also the right thing to do for our business. Being commercially successful and operating responsibly by becoming climate neutral is how we generate sustainable returns. We look forward to sharing more updates on our progress towards this important goal in the near future.

*Scope 1 and 2 according to GHG as well as business travel and employee commuting

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher first-to-market launch: Rivaroxaban across Europe

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.  

Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Rivaroxaban is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. It makes blood flow through veins more easily by stopping a clotting factor called factor Xa from working. Rivaroxaban is also used to reduces the risk of stroke and systemic embolism with nonvalvular atrial fibrillation. The tablets are marketed by our cooperation partner, one of the biggest generic pharmaceutical companies in the world. The new generic offers a more affordable alternative for the treatment of blood clotting making it easier for patients to access the treatment they need.

The product has been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India. Also it has already been launched in several European and international markets before. Overall, Tiefenbacher country scope covers about 70 countries around the world. Furthermore, the successful launch of this anticoagulant reflects our ongoing commitment to providing patients with high-quality, cost-effective medications. Undeniably it is a testament to the hard work and dedication of the team.

Finally, we are particularly excited about the positive impact this achievement will have. However we look forward to further market entries with high-quality medicines – with a patient-centred approach for better healthcare.

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

Tiefenbacher first-to-market launch: Rivaroxaban across Europe
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group welcomes new COO Sandip Tarate

Tiefenbacher Group welcomes new COO Sandip Tarate

We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.

Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the pharmaceutical sector. To induct and orient Sandip to Tiefenbacher family, our Managing Director Kristian Ruepp has visited our plant in Hyderabad to ensure a great employee on-boarding experience.

In view of Sandip’s first day, Kristian has hosted an inspiring town hall meeting underscoring the importance of the value system in our organization. We are energized about the path ahead for AET Laboratories, our customers, and our partners.

This is currently an exciting phase in our growth journey. The photo of the management team with our colleagues from the construction site extension (in front of the newly built High Potent block) is proof that resilience and teamwork can work wonders!

The completion of the new building is the first step for Tiefenbacher Group to become a leading global developer and manufacturer of highly potent drugs for the treatment of cancer and other diseases. It follows our company´s strategy to make medicines more affordable, more available, and better than before.

Tiefenbacher Group welcomes new COO Sandip Tarate
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Featured Video Play Icon

Tiefenbacher Group raises awareness of autism

Tiefenbacher Group raises awareness of autism on today's World Autism Awareness Day.

The aim of World Autism Awareness Day is to draw attention to the needs and lifelong struggles of autistic people worldwide. It was founded on 2 April 2007 by the United Nations General Assembly. This year is being held across Europe under the motto “Not Invisible”. What does “not invisible” mean for autistic people?

Autism is often portrayed as an “invisible disability”. This “invisibility” repeatedly leads to marginalisation in society: parents who are punished with glances because their child breaks social rules. Children and young people who are accused of “not wanting to” and overlooked when it is a matter of “not being able to”. Adults who have to conform at all costs and go far beyond their own limits. Basically it is up to our society to make the needs of autistic people visible and to address them.

In light of this day, we also want to highlight that ADHD is often co-occurring with Autism Spectrum Disorder (ASD), affecting up to 40-50% of people with ASD. With OYSTA, we aim to improve the health of people with these and other conditions through individualized dosing, safe medication management, and treatment support.

However, OYSTA is a cooperation between Tiefenbacher Group and OnDosis. Overall we want to revolutionize how patients take their medicines by combining pharmaceuticals and e-health technology. Thus every individual gets precisely the right dose of the medicine they need in a simpler, more comfortable way via a connected handheld device (under development) and digital solution.

Learn more about OYSTA

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Featured Video Play Icon

Tiefenbacher Group greetings from DCAT Week!

Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!

Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from the Big Apple! These were very successful days for Tiefenbacher Group. During these days we presented our latest product portfolio and innovations to our existing and potential new partners at the DCAT Week in New York City. We love the inspiring atmosphere here and look forward to exciting encounters and interesting discussions on this final day.

DCAT Week is the premier global event held annually in New York City. Especially for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain this event is important. Generally it is hosted by the Drug, Chemical & Associated Technologies Association (DCAT). Emphasising that it is a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group EcoVadis silver medal

Tiefenbacher Group awarded EcoVadis silver medal!

We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!

EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis sustainability assessment methodology is an evaluation of how well a company has integrated the principles of Sustainability/CSR into their business and management system. The Sustainability Scorecard illustrates performance across 21 indicators in four themes:

  • Environment
  • Labor and human rights
  • Ethics
  • Sustainable procurement

The award of the silver medal places our company among the top 15% of companies assessed by EcoVadis in the past 12 months – we even reached the 90th percentile! Thanks a lot to all colleagues at Tiefenbacher API + Ingredients who contribute to this advanced sustainability performance!

We, at TIEFENBACHER GROUP, know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet – in our day-to-day work. That’s why we will continuously strive to achieve our sustainability goals!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group celebrates International Womens Day

Tiefenbacher Group celebrates International Women's Day

Today Tiefenbacher Group celebrates International Women's Day, that's why we would like to introduce you to two valuable female employees from our company.

Get to know the women who are working at Tiefenbacher Group for several years – and take a look at their interesting careers and experiences. They have managed to overcome challenges and successfully shaped their careers. Be inspired and use their tips to start a management career yourself.

That’s why we asked Stefanie Abt (Director of Business Development and Innovation and Director of Project Management) and Breshna Omar (Quality Assurance Manager) to tell us their story.

Hello Stefanie, today is International Womens Day we would like to know more about you and your work for Tiefenbacher Group.

So “How did you begin your professional career?”

Stefanie: “I started my career 21 years ago as a Regulatory Affairs Trainee at Tiefenbacher, following my pharmacy studies. I enhanced my knowledge with a Master’s in Drug Regulatory Affairs and an Executive MBA. A standout experience was a six-month stint in 2006 at AET Laboratories in India, where I gained insights into pharmaceutical development and formed lasting international relationships, deepening my appreciation for Indian culture.” 

 

“What do you particularly like about your position?” 

Stefanie: “What I particularly appreciate about my role is the continuous stream of varied challenges, which keeps me learning new things daily. The blend of portfolio and project management allows me to accompany innovative project ideas from inception to patient delivery. This deep involvement in the entire product lifecycle, from initial concept to market entry, aligns with my passion for developing patient-centric therapies and reinforces my commitment to healthcare. The dynamic collaboration within our international company adds a rich, multicultural dimension to my work, making each day challenging, enjoyable, and constantly varied and enlightening.” 

 

In your opinion “What skills does a leader need? 

Stefanie: “Effective leadership blends resilience, clear communication, and the ability to inspire. Building trust and actively listening are crucial for strong team connections. In a diverse, supportive environment, it’s important to value every voice. Recognizing that we spend much time at work, making it enjoyable is key, as it boosts morale, creativity, and collaboration. A good sense of humor, particularly the ability to laugh at ourselves, is vital and a reminder that while we strive for excellence, the true goal is connection and enjoyment in what we do.” 

 

Could you tell us “What energizes you in your work life?”  

Stefanie: “In my work, the dynamic and ever-changing nature of our projects and challenges is incredibly energizing. The relentless pursuit of innovation in a rapidly evolving environment not only brings unique vibrancy but also a great deal of enjoyment to each day. Collaborating with my team to consistently devise innovative and practical solutions is deeply rewarding. Moreover, there’s a profound sense of fulfillment in seeing the company’s vision align with my own personal vision. This synergy significantly fuels my professional growth. Working in this fantastic company with such wonderful colleagues makes it all the more enjoyable. Helping to foster an environment that is appreciative, globally connected, and truly fun to be part of.” 

 

Finally we would like to know “What advice can you give to women aspiring to leadership positions?  

Stefanie: “My advice is to embrace lifelong learning, face challenges head-on, and nurture a robust professional network. Trust in your abilities and stay adaptable and optimistic, even when plans don’t unfold as expected. Understand that patience is key when progress seems slow. Authenticity is your greatest asset; use your unique skills and viewpoints to your advantage. Choose roles that align with your strengths and passions. Strive for a harmonious balance between your professional and personal life.

Remember, each path is distinct — discover what suits you best. Remain firm in your beliefs and values, while being open to self-reflection. Avoid to be swayed by the opinion of others who have walked different paths and instead embark on your own unique journey guided by your internal compass.

Tiefenbacher Group IWD

Today is International Womens Day Breshna and we are curious to know “How did you start your career at TG?”

Breshna:I started working at Tiefenbacher Group a bit more over 6 years ago. I applied for an open vacancy in Quality Assurance while I was studying for my state exams as a pharmacist and was looking for an apartment in Hamburg. I have very fond memories of my interview – AET took a chance on me by offering me the position even though I didn’t finish my exams yet. They believed in me and gave me even more motivation. The trust continued over the last years, as I could grow within the company and take over more and more responsibilities.”

 

And “What do you particularly like about your position?”

Breshna:Working in the Quality department demands unwavering dedication and attention to detail. It requires us to ensure the safety and effectiveness of medicines, safeguarding the health of millions. That’s why we cannot make compromises when it comes to quality. Every day, we’re driven by the knowledge that our work directly impacts lives, making a difference in the world. I love being part of this responsible department.”

 

Finally we would like to know “What future goals do you want to achieve or advance collectively at Tiefenbacher?”

Breshna: I want to realize my full potential at Tiefenbacher Group; continuously innovate products, services, and processes to stay competitive and meet evolving customer needs by delivering high-quality medicines. Foster a diverse and inclusive work environment where employees feel valued, respected, and empowered to contribute their best.

Because we are celebrating International Women’s Day today, I would like to take the opportunity to draw attention to equal rights for women in the workplace. On this day, we should inform and educate ourselves in order to understand the challenges women face in the workplace.”

We would like to take this opportunity to not only thank Stefanie and Breshna but all female employees of Tiefenbacher Group for their great commitment, everyday passion, and exceptionally good work! Happy International Women´s day!

Tiefenbacher Group celebrates International Womens Day
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group draws attention to Rare Disease Day.

Tiefenbacher Group on awareness for rare disease day

Tiefenbacher Group draws attention to Rare Disease Day.

Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare diseases is insufficient, that´s why we at Tiefenbacher Group are dedicated to protecting and improving lives through innovative healthcare solutions.

In the fight against rare diseases, we are committed to deliver high-quality pharmaceuticals which are better affordable, better available, and better than before. We are glad to offer a refined medication for Wilson Disease, Amifampridine for Lambert-Eaton Myasthenic Syndrome (LEMS) as well as a novel dosage form for a known medicine for Cystinosis – just to name a few of our innovative solutions.

Our culture of caring is essential to achieving our goal of significantly making a difference in the daily lives of people around the world. Therefore we will continue to focus on supporting initiatives like the rarediseaseday organisation that are in line with our values and beliefs.

Tiefenbacher Group draws attention to Rare Disease Day.
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com